Loading...
Market
What will Finch Therapeutics' stock price be at the end of 2024?
3
Resolution / Starting Odds
Below $2 • 25%
$2 to $5 • 25%
Above $10 • 25%
Below $5 • 25%
$5 to $10 • 25%
$10 to $15 • 25%
Above $15 • 25%
Public stock market data (e.g., NASDAQ)
Story
Finch Therapeutics Wins $26 Million Legal Judgment, Stock Soars 350%
Aug 11, 2024, 01:45 AM
Finch Therapeutics (FNCH), a microcap company, has been awarded a legal judgment totaling $26 million, including $25 million in damages and approximately $800,000 in royalties from ITD Rebyota sales. This outcome is significant for the company, which had a market cap of $6 million and cash reserves of around $15 million. The legal victory is expected to boost the company's cash position to over $40 million. The stock, which was valued at less than $1 with a market cap of $1.5 million as of June 2, has seen a substantial increase, rising by approximately 350% since the announcement of the legal judgment. This development marks a notable turnaround for Finch Therapeutics, potentially altering market perceptions of its financial stability.
View original story
Similar markets
Less than 50% • 25%
50% to 100% • 25%
100% to 200% • 25%
More than 200% • 25%
Yes • 50%
No • 50%
Above $25 • 25%
$20 - $25 • 25%
$15 - $20 • 25%
Below $15 • 25%
Less than $20 • 25%
$20 to $30 • 25%
$30 to $40 • 25%
More than $40 • 25%
Increase by more than 10% • 25%
Increase by less than 10% • 25%
Decrease by less than 10% • 25%
Decrease by more than 10% • 25%
Below $0.50 • 25%
$0.50 - $0.99 • 25%
$1.00 - $1.49 • 25%
$1.50 and above • 25%
Below $20 per share • 25%
$20-$24.99 per share • 25%
$25-$29.99 per share • 25%
$30 or above per share • 25%
Below $25 • 25%
$25 - $50 • 25%
$50 - $75 • 25%
Above $75 • 25%
Below $20 • 25%
$20 to $30 • 25%
$30 to $40 • 25%
Above $40 • 25%
Decrease by more than 10% • 25%
Change between -10% and 10% • 25%
Increase by 10% to 20% • 25%
Increase by more than 20% • 25%
Below $20 • 25%
$20 to $40 • 25%
$40 to $60 • 25%
Above $60 • 25%